Resources

PFE – Market expectations are for Uniform ROA to decline, but management is confident about the value of their M&A

October 7, 2019

  • Pfizer Inc. (PFE:USA) currently trades near recent averages relative to UAFRS-based (Uniform) Earnings, with a 15.2x Uniform P/E. At these levels, the market has bearish expectations for the firm, but management is confident about their Array and Mylan transactions
  • Specifically, management is confident Array’s assets fit neatly into Pfizer’s existing business and that the Array deal will close in the near term. Furthermore, they are confident their Mylan deal will unlock significant shareholder value.

You don’t have access to the Valens Research Premium Application.

To get access to our best content including the highly regarded Conviction Long List and Market Phase Cycle macro newsletter, please contact our Client Relations Team at 630-841-0683 or email client.relations@valens-research.com.

Please fill out the fields below so that our client relations team can contact you

Or contact our Client Relationship Team at 630-841-0683